CENSORED: FAUCI SUMMARY VIDEO 6 = Chapter 1, Section 4: Remdesivir

know you’re busy, so I am going to help summarize this book for you in easy 3-minute segments. Find them on TikTok @fatesabitch91

In 2018, well before the “pandemic”, the drug manufacturer Gilead entered the drug Remdesiver in a NIAID-funded clinical trail against Ebola in Africa.

BOOK, Page 63: “However, six months into the Ebola study, the trial’s Safety Review Board suddenly pulled both remdesiver and ZMapp from the trial.”

Why? Because Remdesiver turned out to be horribly dangerous. Within 28 days, subjects who had taken remdesivir had multiple organ failure, acute kidney failure, septic shock, and hypotension - and 54% of the remdesivir group DIED!

For the people in the hospital February of 2020, when they were enrolled to take remdesivir for a clinical trial, we don’t know if those poor souls were warned about toxicity of what they were about to be injected with.

The Gates Foundation has a large equity stake in many pharmaceutical companies that received $125 million in tax-deductible grants (that means YOU paid for them) - this includes the company Gilead that manufactures remdesivir.

Remdesiver cost Gilead $10 per dose to manufacture. When Gilead was granted the Emergency Use Authorization (EUA) then regulators could actually force Medicare and Medicaid to fork over $3,120 per treatment. This is HUNDREDS of times the cost of the drug.

BOOK, Page 66: A Chinese study - that unlike any United States/Big Pharma studies - was actually randomized, double-blind, placebo-controlled, multi-center, and peer-reviewed confirmed how deadly toxic remdesivir was, this was published in The Lancet. No one in government or media talked about this. People unknowingly went to the hospital to be injected with this deadly chemical.

When the FDA recognized remdesivir as the “Standard of Care” - that meant that Medicaid and insurance companies could NOT LEGALLY DENY IT to patients, and would have to pay the exorbitant price tag - this is while U.S. taxpayers had spent $85 million to develop the drug. If we paid for it, why are we paying the pharmaceutical company for it? Hmmmm…

Remdesivir failed to reduce mortality, failed to reduce the need for ventilators, failed to reduce the length of hospital stays, and caused kidney failure between 8% and 31% of patients, depending on the study and length of time on it. Stay tuned for the next installment.